BlackRock Amends Bio-Rad Labs Stake, Signals Continued Passive Holding
Ticker: BIO-B · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns Bio-Rad stock, signaling a stable, passive investment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Bio-Rad Laboratories Inc. Class A Common Stock as of December 31, 2023. This filing, Amendment No. 10, updates their previous disclosures, showing their continued significant, but passive, stake in the company. This matters to investors because BlackRock is a major institutional investor, and their continued holding suggests confidence in Bio-Rad's long-term prospects, even if the exact percentage of ownership isn't detailed in this snippet.
Why It Matters
BlackRock's consistent, passive ownership in Bio-Rad Laboratories Inc. indicates a stable institutional investment, which can reassure other investors about the company's long-term viability.
Risk Assessment
Risk Level: low — This filing is a routine update from a large institutional investor, indicating a passive stake and not suggesting any immediate risks or major changes.
Analyst Insight
An investor should view this as a routine update from a major institutional holder, confirming BlackRock's continued, passive interest in Bio-Rad Laboratories Inc. without signaling any immediate buy or sell action. It reinforces the stability of institutional ownership.
Key Numbers
- 10 — Amendment Number (This is the tenth amendment to BlackRock's Schedule 13G filing for Bio-Rad Laboratories Inc.)
- 090572207 — CUSIP Number (Identifies the Class A Common Stock of Bio-Rad Laboratories Inc.)
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- BIO-RAD LABORATORIES, INC. (company) — the subject company whose Class A Common Stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
- Amendment No: 10 (number) — the specific amendment number of this filing
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Bio-Rad Laboratories Inc. for the foreseeable future. (BlackRock Inc.) — high confidence, target: December 31, 2024
- Bio-Rad Laboratories Inc. will continue its operations in the laboratory analytical instruments sector. (BIO-RAD LABORATORIES, INC.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10)'.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.'.
What company's stock is the subject of this filing?
The subject company is BIO-RAD LABORATORIES, INC., specifically their Class A Common Stock, as noted under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIO-RAD LABORATORIES, INC.' and 'Title of Class of Securities) Class A Common Stock'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed under Rule 13d-1(b), indicated by '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding BIO-RAD LABORATORIES, INC. (BIO-B).